{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:08:36Z","timestamp":1784268516085,"version":"3.55.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Natural autoantibodies (nAAbs) contribute to immune homeostasis and may be altered in patients with autoimmune diseases. While anti-heat shock protein (Hsp) antibodies have been previously described in juvenile idiopathic arthritis (JIA), their relationship with disease severity and treatment effects during remission remains unclear. This study aimed to measure the serum levels of IgM and IgG nAbs against heat shock protein (Hsp) 60 and Hsp70 in children with JIA in remission (mean age: 7.41 years, range:1.27-14.54 years) and to explore their associations with disease subtype, severity, and treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Serum samples from 47 children with JIA in remission and 22 apparently healthy controls (HC) were analyzed. Patient groups were stratified according to the treatment regimen (methotrexate monotherapy versus methotrexate plus adalimumab) and disease subtype and severity. Anti-Hsp60 and anti-Hsp70 IgM and IgG antibodies were measured u\n                      <jats:bold>s<\/jats:bold>\n                      ing an in-house indirect ELISA.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>No significant differences in anti-Hsp60 or anti-Hsp70 nAAb levels were observed between patients with JIA and apparently healthy controls or between treatment groups. However, severity-based analyses revealed significantly lower anti-Hsp60 and anti-Hsp70 IgM levels in patients with polyarticular JIA than in those with milder oligoarticular forms and in apparently healthy controls. No significant differences were observed in the anti-Hsp60 or anti-Hsp70 IgG levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Reduced levels of natural IgM autoantibodies against Hsp60 and Hsp70 are associated with more severe JIA phenotypes during remission, supporting the potential immunoregulatory and protective roles of natural IgM autoantibodies in JIA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1845910","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:43:59Z","timestamp":1784267039000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Reduced IgM natural autoantibody levels against heat shock proteins are associated with disease severity in juvenile idiopathic arthritis"],"prefix":"10.3389","volume":"17","author":[{"given":"Bernadett","family":"Mosd\u00f3si","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Medical School, University of Pecs","place":["Pecs, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"M\u00e1tis","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical School, University of Pecs","place":["Pecs, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1d\u00e1m","family":"Gy\u0151ri","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical School, University of Pecs","place":["Pecs, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panna","family":"Peti","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical School, University of Pecs","place":["Pecs, Hungary"]},{"name":"Department of Immunology and Biotechnology, Medical School, University of Pecs","place":["Pecs, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szabina","family":"Erd\u0151-Bony\u00e1r","sequence":"additional","affiliation":[{"name":"Department of Immunology and Biotechnology, Medical School, University of Pecs","place":["Pecs, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timea","family":"Berki","sequence":"additional","affiliation":[{"name":"Department of Immunology and Biotechnology, Medical School, University of Pecs","place":["Pecs, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Simon","sequence":"additional","affiliation":[{"name":"Department of Immunology and Biotechnology, Medical School, University of Pecs","place":["Pecs, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60363-8","article-title":"Juvenile idiopathic arthritis","volume":"369","author":"Ravelli","year":"2007","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1186\/ar2674","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2013.09.003","article-title":"Prevalence and incidence of juvenile idiopathic arthritis: a systematic review","volume":"81","author":"Thierry","year":"2014","journal-title":"Joint Bone Spine"},{"key":"B4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s40744-016-0040-4","article-title":"Juvenile idiopathic arthritis: diagnosis and treatment","volume":"3","author":"Giancane","year":"2016","journal-title":"Rheumatol Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00332-8","article-title":"Juvenile idiopathic arthritis","volume":"8","author":"Martini","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000001028","article-title":"Novel therapies in juvenile idiopathic arthritis","volume":"36","author":"Sage","year":"2024","journal-title":"Curr Opin Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000001099","article-title":"Pathogenesis of juvenile idiopathic arthritis","volume":"37","author":"Simonds","year":"2025","journal-title":"Curr Opin Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2006.06.006","article-title":"Frequency of anti-hsp60, -65 and -70 antibodies in sera of patients with juvenile idiopathic arthritis","volume":"27","author":"Zlacka","year":"2006","journal-title":"J Autoimmun"},{"key":"B9","first-page":"99","article-title":"Incidence of anti Hsp 90 and 70 antibodies in children with SLE, juvenile dermatomyositis and juvenile chronic arthritis","volume":"14","author":"Conroy","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)93057-g","article-title":"Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis","volume":"337","author":"De Graeff-Meeder","year":"1991","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.5114\/ceji.2018.81354","article-title":"Natural antibodies - facts known and unknown","volume":"43","author":"Palma","year":"2018","journal-title":"Cent Eur J Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-014-0025-4","article-title":"Natural IgM: beneficial autoantibodies for the control of inflammatory and autoimmune disease","author":"Gr\u00f6nwall","year":"2014","journal-title":"J ClinImmunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.01.006","article-title":"Natural autoantibodies in the physiology and pathophysiology of the immune system","volume":"41","author":"Avrameas","year":"2013","journal-title":"J Autoimmun"},{"key":"B14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1054\/csac.1998.0121","article-title":"Identification of human heat shock protein 60 (Hsp60) and anti-Hsp60 antibodies in the peripheral circulation of normal individuals","volume":"4","author":"Pockley","year":"1999","journal-title":"Cell Stress Chaperones"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00198","article-title":"Role of natural autoantibodies and natural IgM anti-leucocyte autoantibodies in health and disease","volume":"7","author":"Lobo","year":"2016","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.12.002","article-title":"Definition of human autoimmunity--autoantibodies versus autoimmune disease","volume":"9","author":"Lleo","year":"2010","journal-title":"Autoimmun Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21031138","article-title":"Natural autoantibodies in chronic pulmonary diseases","volume":"21","author":"Fukushima","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/cei.13521","article-title":"Relationship between natural and infection-induced antibodies in systemic autoimmune diseases (SAD): SLE, SSc and RA","volume":"203","author":"B\u00f6r\u00f6cz","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.686483","article-title":"Increased frequency of activated switched memory B cells and its association with the presence of pulmonary fibrosis in diffuse cutaneous systemic sclerosis patients","volume":"12","author":"Simon","year":"2021","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/art.21389","article-title":"Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis","volume":"31","author":"Wallace","year":"2004","journal-title":"J Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076439","article-title":"Complexity of the immune response elicited by different COVID-19 vaccines, in the light of natural autoantibodies and immunomodulatory therapies","volume":"24","author":"B\u00f6r\u00f6cz","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-5890(01)00025-6","article-title":"Role of natural and immune IgM antibodies in immune responses","volume":"37","author":"Boes","year":"2000","journal-title":"Mol Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1391.020","article-title":"Stress, heat shock proteins, and autoimmunity: how immune responses to heat shock proteins are to be used for the control of chronic inflammatory diseases","volume":"1113","author":"Van Eden","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1421528","article-title":"Dual role of autoantibodies to heat shock proteins in autoimmune diseases","volume":"15","author":"Tukaj","year":"2024","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1196\/annals.1366.029","article-title":"The role of chaperone proteins in autoimmunity","volume":"1088","author":"Routsias","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2004.04.011","article-title":"The natural autoantibody repertoire and autoimmune disease","volume":"58","author":"Quintana","year":"2004","journal-title":"BioMed Pharmacother"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s12192-018-0951-9","article-title":"Autoantibodies to heat shock proteins 60, 70, and 90 in patients with rheumatoid arthritis","volume":"24","author":"Mantej","year":"2019","journal-title":"Cell Stress Chaperones"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0373-9","article-title":"Methotrexate and its mechanisms of action in inflammatory arthritis","volume":"16","author":"Cronstein","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040165","article-title":"Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy","volume":"200","author":"Ehrenstein","year":"2004","journal-title":"J Exp Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/ar2399","article-title":"Extracellular heat shock protein 70 inhibits tumour necrosis factor-alpha induced proinflammatory mediator production in fibroblast-like synoviocytes","volume":"10","author":"Luo","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2007.04.082","article-title":"Cell stress induced HSP are targets of regulatory T cells: a role for HSP inducing compounds as anti-inflammatory immuno-modulators","volume":"581","author":"Wieten","year":"2007","journal-title":"FEBS Lett"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1186\/ar144","article-title":"The stressed synovium","volume":"3","author":"Schett","year":"2001","journal-title":"Arthritis Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102626","article-title":"The pathophysiological role of heat shock response in autoimmunity: a literature review","volume":"10","author":"Androvitsanea","year":"2021","journal-title":"Cells"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111683","article-title":"The spleen modulates the balance of natural and pathological autoantibodies in a mouse model of autoimmune arthritis","volume":"25","author":"Olasz","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"11731","DOI":"10.1038\/s41598-022-15676-8","article-title":"A human IgM-enriched immunoglobulin preparation, Pentaglobin, reverses autoimmune diabetes without immune suppression in NOD mice","volume":"12","author":"Wilson","year":"2022","journal-title":"Sci Rep"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1845910\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:44:00Z","timestamp":1784267040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1845910\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":35,"alternative-id":["10.3389\/fimmu.2026.1845910"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1845910","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"article-number":"1845910"}}